Healthy volunteers to test two batches of new diabetes drug

NCT ID NCT07670897

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage trial will check whether two different ways of making the experimental drug GZR4 produce the same levels in the blood. About 64 healthy men will receive a single shot of one version or the other. The study is not designed to treat diabetes, but to ensure future batches are consistent.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

GZR4 injection

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for T2D are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Gan & Lee Pharmaceuticals Shandong Co., Ltd.,

    Linyi, Shandong, 276000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••